NCT07083583View on ClinicalTrials.gov

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 8, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Bleeding DisordersIronPlateletBleeding
Interventions
DRUG

IV Iron (standard of care)

Participants will receive IV iron therapy as part of standard management for iron deficiency

Trial Locations (1)

15232

RECRUITING

Hemophilia Center of Western Pennsylvania, Pittsburgh

All Listed Sponsors
collaborator

Health Resources and Services Administration (HRSA)

FED

lead

Nicoletta C Machin

OTHER

NCT07083583 - Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders | Biotech Hunter | Biotech Hunter